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The recently discovered hum.an virus known as Ka-
posi's sarcom.a-associated herpesvirus (KSHV) or hu-
m.an herpesvirus-8 (HHV -8) has been associated with 
body-cavity-based lym.phom.as in AIDS patients. It is 
m.ost closely related to two other herpesviruses, the 
Epstein-Barr virus and herpesvirus saim.iri, which are 
known to be associated with lym.phom.as in hum.ans 
and nonhum.an prim.ates, respectively. To determ.ine 
whether KSHV/HHV -8 is involved in the pathogene-
sis of m.ycosis fungoides (MF) and related disorders, 
we used a genom.ic PCR assay followed by confirm.a-
tory Southern blot analysis with a nested oligonucle-
otide probe to analyze cases for the presence of this 
virus. The specim.ens studied included fresh-frozen 
lesional tissues obtained from. 16 patients with MF, 
seven with lym.phom.atoid papulosis, seven with pri-
A new human herpesvirus, designated Kaposi's sarco-ma-associate d herpesvirus (KSHV) or human her-pesviru s-8 (HHV -8) was first detec ted by Chang and co-workers (1994) in patients with acquired immu-nodeficie n cy syndrome-associated Kaposi's sarcoma. 
By using representational diH'erence analysis, they identified two 
D1'fA fragments whose base sequence shares the most homology 
with, but is distinct fj'om, two human herpesviruses, Epstein-Barr 
vinls and h erpesvirus saimiri. These viruses are characterized by 
their ability to persist in Band T lymphocytes, respectively, and to 
immortalize these cells, leading to the development of lymph ore-
ticular malignancies (Fleckstein and Desrosiers, 1982; Miller, 1990; 
Roizman, 1990; Biesinger e/: ai, 1992). Epstein-Barr virus immor-
talizes B cells ill "itro and is associated with Burkitt's lymphoma and 
Hodgkin's disease. Herpesvirus sairniri causes no disease in its 
natural bost, the squirrel monkey, but can cause T-cell lymphomas 
in other nonhuman primates. G iven the association of these two 
viruses with lymphoreticular neoplasms, their homology to KSHV I 
HHV -8, and the fact that KSHV IHHV -8 has been detected in 
100% of acquired immunodeficiency syndrome-associated body-
cavity-based lymphomas (CesaTman el ai, 1995), we were inter-
ested in the potential role of this novel vims in the pathogenesis of 
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m.ary cutaneous CD30+ large celllym.phom.a ofT-cell 
lineage, and five with Hodgkin's disease. Two T-cell 
tum.or lines were also studied: MT4 (derived from. a 
patient with adult T-cell leukem.ia/lym.phom.a) and 
Jurkat (derived from. a patient with T-cell acute 
lym.phoblastic leukem.ia). All cases were uniform.ly 
negative for KSHV/HHV-8, whereas Kaposi's sarco_ 
m.a-positive controls and hum.an /3-globin DNA in-
tegrity controls were appropriately positive. These 
findings provide strong evidence against a role for 
KSHV/HHV-8 in the pathogenesis of MF or associ-
ated lym.phoproliferative disorders. Key words: Illmlan 
herpesl!irlls-8IKaposi's sarcoma-associated I,erpesvil'llslly",-
plwmatoid pap,,[osisllarge celllympltolllalHodgkill's disease. 
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cutaneous lymphoproliferative disorders. Therefore, we used poly-
m e rase chain reaction (PCR)-based methods to search for evidence 
ofKSHV/HHV-8 viral infection in 35 cases of mycosis fungoides 
(MF) and associated diseases, as well as two non-MF T-cell tumor 
lines. 
MA TERlALS AND METHODS 
Patients and Cell Lines All specimens were obtained from the frozen 
tissue library in the Department of Dermatology at Case W estern Reserve 
University. Patients were diagnosed and staged by standard clinicopatho-
logic criteria (Wood, 1992). Selected features of these cases are summarized 
in R.esults. All biopsy specimens were obtained with informed consent and 
institutional review board approval. In addition to the biopsy specimens, 
two T-cell tumor lines were also studied including the human T-Iympho-
tropic virus type I (HT.lV-I)-positive MT4 cell line derived from a patient 
with adult T-celileukemia/lymphoma and the Jurkat cell line derived from 
a patient with T-cell acute lymphoblastic leukemia. 
DNA Preparation Genomic DNA was prepared by incubating the tissue 
biopsy or cell pellet in 500 loOd of an extraction buffer containing O.S X 
standard saline citrate, 0.2 M NaCI, 0.5% sodium dodecyl su lf.~te, 1 mM 
dithiothreitol, and 0.1 mg proteinase K per m1. After overnight incubation 
at 56°C, samples were extracted twice with phenol and once with chloro-
form. DNA was precipi tated overnight with ethanol at -20°C and then 
resuspended in 100 ILl of 10 mM Tris(hydro"'Ymethyl)aminomethane, pH 
8.0, containing 1 111M ethylenediamine tetr.acetic acid. 
PCR Amplification PCR amplification of the 233-bp KS330 233 frag-
ment specific for KSHV I HHV:'8 was performed with primers described by 
Chang el nl (1994). PCR amplification of the 123-bp human {3-globin gene 
fragment, using upstream 5'-GCTTCTGACACAACTGTGTT-3' and 
downstream 5'-CACCACCACTTCATCCACG-3' primers based on pub-
lished sequences (Lawn el nl, 1980), was carried Ollt for all DNA prepara-
tions as a meaSllre of DNA quality. Each 100-ILI reaction contained 0.5 ILg 
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of genomic DNA, 1 f.Lg of eoch primer, all four deoxynuc1eotide triphos-
phates (eoch ot 0.2 mM), ond 3 un.its of Taq polymerase ill 10 mM 
Tris(hydfm,:ymethyl) llminomethane, pH S.3, 1.5 mM MgCl20 and 50 mM 
KCl. PCR cycling pOfometers were os follows: 94°C fOf 1 min, 5SoC for 1 
min, 72°C for 1 min (35 cycles) and a 72°C extension fOf 5 min (one cyclc). 
Lesional tissuc 6:om a patient with Kaposi's sarcoma served as a positive 
control for KSHV / HHV-B. Negative controls included carry-over controls 
containing all reagents except target DNA. 
Southern Blot Analysis of PCR-Alnplified Fragments PCR-
amplified fragments werc electrophoretical1y separated on a 2% agarose gel, 
ttansferred to nylon membranes (Amersham) , and probed with oligon.ucle-
otides labeled with the ECL 3' oligolabcling and detection system. Nucle-
otide sequences of the nested probes for the KS330233 fragment and the 
human ,a-globin gene fragment were S'-TGCAGCAGCTGTTGGTG-
TACC and S'-TCAAACAGACACCATGGTGC-3', respectively. 
RESULTS 
Clinicopathologic Features Fom groups of patients were 
studied with tbe following diseases: MF (n = 16), lymphomatoid 
papulosis (n = 7), primary cutaneous CD30 + large cell lymphoma 
of T -cell lineage (n = 7), and Hodgkin's disease (n = 5). T he MF 
group included six men and ten women with five in stage la, six in 
stage Ib, two in stage lib, one in stage IIIb, and two in stage IVa. 
All w-ere MF-rype rather tban Sezary syndrome. All were from 
Ohio. The tissues studied included seven patches, SLX plaques, two 
tumors, and one erythrodenna . T he lymphomatoid papulosis group 
included four men and three women. Six were from Ohio and one 
was from Switzerland. All specimens were lesional skin. The large 
cell lymphoma gro up included six men and one woman. There 
were six analplastic type and one immunoblastic type. One patient 
was from Ohio, three were from Switzerland, and three were from 
Japan. The tissues studied included six skin lesions and one 
involved lymph node. T he Hodgkin's disease group included fom 
men and one woman. Three cases were mixed cellulariry type and 
two were nodular sclerosis type. Four patients were from Califomia 
and one was &'om Japan . The tissue studied included fom involved 
lyxnpb nodes and one subcutaneous lesion. AI] patients studied were 
middle-aged or elderly (range 34-84 y old) except for two patients 
".rith MF and one with Hodgkin's disease who were 18-24 y o ld . 
All biopsy specimens were obtained prior to treatment except in 
four cases of MF. 
peR/Southern Blot Analysis Shows No Detectable KSHVI 
HHV -8 PCR analysis of DNA obtained from fi'esh-frozen sam-
ples of all specimens was uniformly negative for the 233-bp 
KSHV IHHV-8 sequence except for the Kaposi's sarcoma-positive 
control. The negative samples included lesional tissue obtained 
fron. 16 patients with MF, seven with lymphomatoid pap ulosis, 
seven with primary cutaneous CD30 + large cell lymphoma of 
T -ceU lineage, five with Hodgkin's disease, and the T -cell lines 
MT4 (HTLV-r+) and Jurkat (HTLV-I - ). The results were con-
firmed by Southern blot ana lysis using a nested oligonucleotide 
probe. Representative findings are shown in Fig 1. Positive results 
for the human {3-globin gene verified the integrity of the DNA in 
all specinlens. 
DISCUSSION 
The lack of detectable KSHV IHHV -8 in MF and associated 
disorders suggests that tlus newly recognized DNA virus is not 
involved in the pathogenesis of these diseases. Our findings are in 
agreement with one prior study of 193 human lymphomas that 
included some cases of MF and rela ted diseases (Cesarman el ai, 
1995). In this series, al.! cases except body-cavity-based lymphomas 
were uniformly negative for KSHV IHHV -8; however, the number 
of cases of MF and related diseased studied was relatively small , and 
no data were given concenung the clinicopathologic or im111uno-
phenotypic subtypes of disease studied, patient age and sex, geo-
graphical origin, stage of disease, prior treatment, or type of lesion 
or type of tissue sampled . Specification of these features is impor-
tan t w hen a viral etiology is being considered because it is possible 
that a viral agent might be restricted to specific geographic locations 
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Figure 1. HHV-8 is not present in MF or associated disorders. 
HHV-8 PCR/Southern blot analysis of MF, CD30+ large cell lymphoma, 
and lymphomatoid pap ulosis. Ugandon Kaposi's sarcoma-positive control 
shows the expected HHV-B 233-bp sequence (lnlle 3). All other lanes are 
negative including eight case of MF, three cases of CD30+ large cell 
lymphoma (LCL), two cases oflymphomatoid papulosis (LyP), and negative 
controls including the Jurkat T-cell line OUR) and carryover (CO) . In 
addition, eight other cases of MF, four of LCL, five of LyP, five cases of 
Hodglcin 's disease, and the HTLV-l + T-cell line MT4 were negative for 
HHV-8 (results not shown). 
and/or phases of disease development or might be affected by one 
or more of these other factors. Furthermore, MF-associated diseases 
such as lymphomatoid papulosis and primary cutaneous CD30 + 
large cell lymphoma ofT-ceil lineage were not specifically included 
among those studied previonsly. Because these diseases are known 
to be clonally related to MF when they coexist in individual patients 
(Wood et aI , 1995), it is likely that they would also contain any virus 
found to be involved in the pathogenesis of MF. 
Our current findings confirm and extend tile earlier results. 
Together, they provide information on 24 cases of MF, 12 cases of 
Hodgkin's disease, 7 cases of primary cutaneous CD30 + large cell 
lymphoma of T -cell lineage, and 7 cases of lymphomatoid papulo-
sis. There was no molecular biologic evidence for KSHV / HHV-8 
playing a role in the development of any of these MF-associated 
Iymphoproliferative disorders. 
These results are also in general agreement with preliminary 
studies of cutaneous lymphoproliferative disorders by another 
group.' In this study, most cases were negative for KSHV IHHV-8, 
although a sma]] percentage were positive by PCR. The possibility 
of false positives could not, however, be excluded in this series, 
especia]]y because DNA was extracted from arcluval paraffin 
specimens that might have been contaminated with exogenous viral 
DNA during tissue processing or sectioning. In contrast, tile DNA 
in our current study was extracted from fresh- frozen tissues that 
were in neither direct nor indirect contact with other tissue 
specimens. 
Although a viral etiology for MF and associated diseases has been 
suspected for some time, to date there has been no convincing 
evidence for any particular agent. In recent years, the retrovirus, 
HTLV-ll, has been ruled out as an etiologic factor. Some residual 
controversy not withstand.ing, most studies also exclude the related 
agent HTLV -I, despite the fact that it is clearly associated with adult 
T-cell leukem.ia/ lymphoma (Li el ai, 1996; Wood et ai, 1996) . It 
appears that KSHV IHHV -8 can be added to tlus list of excluded 
suspects. 
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